Tactile Systems Technology Inc Cmn (TCMD) 17.98

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tactile Systems Technology Inc Cmn (TCMD) 17.98 $TCMD

Tactile Systems Technology, Inc. Reports Second Quarter 2016 Financial Results and Introduces Fiscal Year 2016 Outlook; Q2 Revenue Increased 34% Year-over-Year
GlobeNewswire - Wed Sep 07, 3:05PM CDT
Tactile Systems Technology, Inc. ("Tactile Medical" (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the second quarter ended June 30, 2016.
TCMD: 17.98 (-1.54)

Tactile Systems Announces Closing of Initial Public Offering
GlobeNewswire - Tue Aug 02, 3:06PM CDT
Tactile Systems Technology, Inc. ("Tactile Medical" (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced today the closing of its initial public offering of 4,120,000 shares of common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions. All shares of the common stock in this offering are being sold by Tactile Medical. Tactile Medical's common stock began trading on The NASDAQ Global Market on July 28, 2016 under the ticker symbol "TCMD."
TCMD: 17.98 (-1.54)

Nasdaq Welcomes Tactile Medical to The Nasdaq Stock Market
GlobeNewswire - Tue Aug 02, 9:00AM CDT
Nasdaq (Nasdaq:NDAQ) announced that trading of Tactile Systems Technology, Inc., doing business as Tactile Medical, (Nasdaq:TCMD) commenced on The Nasdaq Stock Market on July 28, 2016.
TCMD: 17.98 (-1.54), NDAQ: 69.80 (+0.33)

Tactile Systems Announces Pricing of Initial Public Offering
GlobeNewswire - Wed Jul 27, 8:00PM CDT
Tactile Systems Technology, Inc. ("Tactile" (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced today the pricing of its initial public offering of 4,000,000 shares of common stock at a public offering price of $10.00 per share.
TCMD: 17.98 (-1.54)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading